Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10830	Companies
234972	Keywords
163853	Articles
125780	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 09/24/2025 at 15:00, 10 months 18 days ago

Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition
Jaguar Health's Napo Pharmaceuticals submits orphan drug designation application to FDA for crofelemer in treating diarrhea in adult patients with breast cancer metastasized to the brain, targeting expedited regulatory pathways

FDA Napo Pharmaceuticals Crofelemer Jaguar Health Breast Cancer
BRIEF

published on 09/23/2025 at 15:05, 10 months 19 days ago

Jaguar Health participera à des conférences clés en septembre 2025

Jaguar Health Médicaments À Base De Plantes Médicament Approuvé Par La FDA Conférences Virtuelles Traitements Gastro-intestinaux
BRIEF

published on 09/23/2025 at 15:05, 10 months 19 days ago

Jaguar Health to Present at Key Conferences in September 2025

Jaguar Health Plant-based Medicines FDA-approved Drug Virtual Conferences Gastrointestinal Treatments
PRESS RELEASE

published on 09/23/2025 at 15:00, 10 months 19 days ago

Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts
Jaguar Health, Inc. announces CEO Lisa Conte's virtual presentations at upcoming conferences. The company focuses on developing plant-derived medicines for gastrointestinal distress

Pharmaceuticals Gastrointestinal Distress Jaguar Health Lisa Conte Virtual Presentations
BRIEF

published on 09/05/2025 at 15:05, 11 months 7 days ago

Jaguar Health participera à la conférence mondiale sur l'investissement HC Wainwright

Jaguar Health Médicaments Santé Gastro-intestinale HC Wainwright Présentation De La Conférence
BRIEF

published on 09/05/2025 at 15:05, 11 months 7 days ago

Jaguar Health to Present at H.C. Wainwright Global Investment Conference

Pharmaceuticals Jaguar Health Conference Presentation H.C. Wainwright Gastrointestinal Health
PRESS RELEASE

published on 09/05/2025 at 15:00, 11 months 7 days ago

Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts
Jaguar Health, Inc. to present at H.C. Wainwright 27th Annual Global Investment Conference. Lisa Conte to discuss pharmaceutical developments for gastrointestinal distress

Pharmaceuticals Gastrointestinal Distress Lisa Conte Jaguar Health Inc. H.C. Wainwright Conference
BRIEF

published on 08/21/2025 at 15:05, 11 months 22 days ago

Jaguar Health vise une expansion mondiale pour Canalevia®

Jaguar Health Approbation De La FDA Canalevia Traitement De La Diarrhée Canine Sommet Sur La Santé Animale
BRIEF

published on 08/21/2025 at 15:05, 11 months 22 days ago

Jaguar Health Targets Global Expansion for Canalevia®

FDA Approval Jaguar Health Canalevia Dog Diarrhea Treatment Animal Health Summit
PRESS RELEASE

published on 08/21/2025 at 15:00, 11 months 22 days ago

Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia's Indication to Treatment of General Diarrhea in Dogs
Jaguar Health announces conditional FDA approval of Canalevia-CA1 for CID in dogs and strategic plans to expand indication for general diarrhea treatment globally. Participation in 2025 Animal Health Summit

FDA Approval Canalevia-CA1 Partnerships Animal Health Diarrhea Treatment

Accesswire

Published on 08/13/2026 at 08:00, 41 minutes ago

Battery X Metals Maintains Y Lithium Project Claims in Good Standing and Evaluates Phase I Exploration Program
Published on 08/13/2026 at 07:30, 1 hour 11 minutes ago

Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
Published on 08/13/2026 at 00:30, 8 hours 11 minutes ago

Aton Closes CAD$4 Million Private Placement
Published on 08/12/2026 at 23:30, 9 hours 11 minutes ago

CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:30, 9 hours 11 minutes ago

Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle

View all ACCESSWIRE

EQS Group

Published on 08/13/2026 at 08:30, 11 minutes ago

AMOI announces pre-RTO Subscriptions
Published on 08/13/2026 at 08:30, 11 minutes ago

Restoration: Octagon Healthcare Funding plc
Published on 08/13/2026 at 08:30, 11 minutes ago

FRIWO’s performance in the first half of the year shaped by a challenging environment – significantly improved order situation is cause for optimism
Published on 08/13/2026 at 08:05, 36 minutes ago

SWI Group accelerates transition into Digital Infrastructure
Published on 08/13/2026 at 08:04, 37 minutes ago

Genel Energy PLC: Operational Update

Les Echos

Published on 08/11/2026 at 17:45, 1 day 14 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 15 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 14 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 14 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 14 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE